Synopsis
Recognise pancytopenia as a multilineage syndrome, stabilise infection or bleeding, and distinguish marrow underproduction or infiltration from peripheral destruction and splenic sequestration.
- Pancytopenia means reduction in red cells, white cells and platelets; it is a syndrome and does not specify whether the dominant mechanism is production failure, ineffective maturation, infiltration, consumption or sequestration.
- Confirm the result and trajectory on a fresh FBC and expert film, but assess fever, bleeding, breathlessness, chest pain, syncope and neurological change before waiting for a repeat in an unwell patient.
- Reticulocytes define the erythroid branch: a low response supports underproduction or ineffective erythropoiesis, while a raised response suggests red-cell loss or destruction with preserved erythroid capacity but does not by itself explain the white-cell and platelet reductions.
- The film can reveal blasts, abnormal promyelocytes, macro-ovalocytes, hypersegmented neutrophils, schistocytes, teardrops, parasites or a leucoerythroblastic pattern and can make the pathway urgent.
- Review every prescribed, non-prescribed and recreational exposure, including chemotherapy, immunosuppressants, antimicrobials, antiepileptics, alcohol and occupational or deliberate toxin exposure.
- Severe B12 or folate deficiency can mimic marrow malignancy through cytopenia, high LDH and abnormal morphology; neurological B12 features require urgent replacement after diagnostic sampling.
- Splenomegaly suggests sequestration, portal disease, infection or haematological malignancy, but hypersplenism remains a diagnosis integrated with marrow response and the cause of enlargement.
- Bone-marrow aspiration and trephine are indicated when serious persistent pancytopenia remains unexplained or acute leukaemia, aplasia, myelodysplasia, fibrosis or infiltration is suspected.
Key red flags
Fever, rigors, hypotension, confusion or focal infection with significant neutropenia is an emergency; inflammatory signs may be muted and treatment should follow the neutropenic-sepsis pathway.
Blasts or abnormal promyelocytes, bruising, infection, bone pain, gum change, lymphadenopathy or splenomegaly with rapidly evolving counts demands urgent haematology assessment.
Sepsis, shock, thrombocytopenia, prolonged coagulation, falling fibrinogen or schistocytic haemolysis suggests DIC or TMA and redirects management from isolated marrow failure.
Investigation priorities
Confirm multilineage abnormality, detect artefact and identify urgent morphology.
Management branches
Pancytopenia accompanies fever, sepsis, active bleeding, neurological change, chest pain, syncope or haemodynamic instability.
- Use ABCDE, cultures and urgent blood tests, examine for bleeding and infection, and contact haematology and transfusion early while preserving film, flow, coagulation and haemolysis samples.
- First-line treatment follows the emergency phenotype: immediate guideline antibiotics for neutropenic sepsis, major-haemorrhage support for significant bleeding, and symptom-led red-cell support rather than delay for final marrow classification.
- Escalate abnormal promyelocytes, DIC, leukostasis, TMA, shock or organ ischaemia to critical care and the appropriate specialist pathway; avoid prophylactic correction unsupported by bleeding or procedure guidance.
The patient is stable enough for a structured causal work-up after immediate threats are addressed.
- Obtain repeat FBC, film and absolute reticulocytes, then review medicines, alcohol, nutrition, infection, liver disease, autoimmunity, cancer, travel and spleen findings.
- Low reticulocytes favour a production pathway with haematinics and early marrow consideration; a regenerative response favours the alternative haemolysis, bleeding, consumption or hypersplenism pathway.